Changes in regulatory B-cell levels in bone marrow, blood, and sputum of patients with asthma following inhaled allergen challenge - 05/04/18
Disclosure of potential conflict of interest: P. M. O'Byrne personally received board membership from Joint Oversight Board for LABA safety study and consultancy fees from AstraZeneca, GSK, Merck, and Boehringer; his institution received grants from AstraZeneca, Amgen, and Genentech for other works. R. Sehmi's institution received grants from GalxoSmithKline, AstraZeneca, Genetech, Sanofi Regeneron, and AllerGen NCE for other works. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 141 - N° 4
P. 1495 - avril 2018 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?